Viewing Study NCT04765059


Ignite Creation Date: 2025-12-24 @ 2:50 PM
Ignite Modification Date: 2025-12-26 @ 10:31 AM
Study NCT ID: NCT04765059
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-01
First Post: 2021-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module